Nome |
# |
Facciamo il punto: miocardio non compatto, file e2913fdf-368c-f688-e053-3705fe0a67e0
|
3.854
|
Documento di consenso ANMCO/FADOI/SIAARTI/SIC/SIMG/SIMI/SIMEU: Il percorso clinico-diagnostico e terapeutico del paziente con scompenso cardiaco acuto dal domicilio alla dimissione dal Pronto Soccorso/ Dipartimento di Emergenza-Accettazione, file e2913fdf-32ce-f688-e053-3705fe0a67e0
|
3.634
|
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema, file e2913fdf-492e-f688-e053-3705fe0a67e0
|
3.369
|
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019, file e2913fde-f4ed-f688-e053-3705fe0a67e0
|
3.284
|
Insufficienza tricuspidale e indicazioni al trattamento, file e2913fdf-22d0-f688-e053-3705fe0a67e0
|
1.207
|
Takotsubo is not a cardiomyopathy, file e2913fdb-f033-f688-e053-3705fe0a67e0
|
510
|
Elevations of inflammatory markers PTX3 and sST2 after resuscitation from cardiac arrest are associated with multiple organ dysfunction syndrome and early death, file e2913fd9-e14c-f688-e053-3705fe0a67e0
|
376
|
Routine use of bilateral internal thoracic artery grafts for left-sided myocardial revascularization in insulin-dependent diabetic patients: early and long-term outcomes, file e2913fd9-9cbb-f688-e053-3705fe0a67e0
|
374
|
Value of Strain Imaging and Maximal Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy, file e2913fdb-f37e-f688-e053-3705fe0a67e0
|
344
|
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry, file e2913fdf-4f44-f688-e053-3705fe0a67e0
|
314
|
Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library, file 83471447-ebfe-4bbf-b843-55233129c309
|
288
|
Reference Values for Peak Exercise Cardiac Output in Healthy Individuals, file e2913fdc-0bfc-f688-e053-3705fe0a67e0
|
285
|
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score, file e2913fdc-f62b-f688-e053-3705fe0a67e0
|
272
|
Dilated Cardiomyopathy. From Genetics to Clinical Management, file e2913fdd-2423-f688-e053-3705fe0a67e0
|
262
|
Arrhythmic risk stratification by cardiac magnetic resonance tissue characterization: disclosing the arrhythmic substrate within the heart muscle, file e2913fdf-8ba6-f688-e053-3705fe0a67e0
|
258
|
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies, file e2913fda-7ec2-f688-e053-3705fe0a67e0
|
255
|
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders, file e2913fde-f755-f688-e053-3705fe0a67e0
|
247
|
Role of Titin Missense Variants in Dilated Cardiomyopathy, file e2913fda-06bf-f688-e053-3705fe0a67e0
|
243
|
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial, file e2913fdb-f733-f688-e053-3705fe0a67e0
|
236
|
Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis, file af5565cc-a6f4-41ab-aa45-9b162d772ff2
|
230
|
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives, file e2913fdc-6ac9-f688-e053-3705fe0a67e0
|
226
|
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies, file ada7573b-88e5-40dd-9c1c-f795b21c97cd
|
223
|
The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases, file dce9b366-97c0-4de0-98bf-43a42b103376
|
218
|
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction, file 54424231-ca02-4118-b866-5d238370b25f
|
212
|
Multi-state modelling of heart failure care path: A population-based investigation from Italy, file e2913fdb-c6c6-f688-e053-3705fe0a67e0
|
208
|
Implantable cardioverter-defibrillator-computed respiratory disturbance index accurately identifies severe sleep apnea: The DASAP-HF study, file e2913fdb-fd1e-f688-e053-3705fe0a67e0
|
208
|
Exercise performance, haemodynamics, and respiratory pattern do not identify heart failure patients who end exercise with dyspnoea from those with fatigue, file e2913fdb-f72b-f688-e053-3705fe0a67e0
|
205
|
Cardiac Tumors: Diagnosis, Prognosis, and Treatment, file e2913fde-08b7-f688-e053-3705fe0a67e0
|
198
|
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry, file e2913fde-f4e7-f688-e053-3705fe0a67e0
|
189
|
Myocarditis in Clinical Practice, file e2913fdf-501f-f688-e053-3705fe0a67e0
|
187
|
Cardiac fluid dynamics meets deformation imaging, file e2913fdb-d621-f688-e053-3705fe0a67e0
|
184
|
Effect of prehospital treatment in STEMI patients undergoing primary PCI, file e2913fdf-6a23-f688-e053-3705fe0a67e0
|
184
|
Restrictive cardiomyopathy: definition and diagnosis, file a1ded043-40c4-47b3-80cc-0dee95734dcd
|
182
|
Natural History of Dilated Cardiomyopathy in Children, file e2913fda-8192-f688-e053-3705fe0a67e0
|
181
|
Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits, file e2913fdc-d154-f688-e053-3705fe0a67e0
|
178
|
Mineralocorticoid receptor antagonists for heart failure: a real-life observational study, file e2913fdc-4961-f688-e053-3705fe0a67e0
|
177
|
Is heart failure with preserved ejection fraction a ‘dementia’ of the heart?, file 37591231-4e0b-4510-b950-9f5a766aaa06
|
175
|
Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study, file e2913fdc-4358-f688-e053-3705fe0a67e0
|
175
|
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction, file e2913fdd-11db-f688-e053-3705fe0a67e0
|
173
|
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History, file e2913fdd-3de0-f688-e053-3705fe0a67e0
|
171
|
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs, file e2913fdc-8c19-f688-e053-3705fe0a67e0
|
170
|
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes., file e2913fd9-1915-f688-e053-3705fe0a67e0
|
169
|
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias, file e2913fda-9b7d-f688-e053-3705fe0a67e0
|
169
|
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures, file e2913fdc-c669-f688-e053-3705fe0a67e0
|
163
|
Pulmonary hypertension and pregnancy outcomes: data from the Registry Of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology, file e2913fdf-4af1-f688-e053-3705fe0a67e0
|
154
|
Association between beta-blocker use and mortality/morbidity in older patients with heart failure with reduced ejection fraction. A propensity score-matched analysis from the Swedish Heart Failure Registry, file e2913fdc-f62a-f688-e053-3705fe0a67e0
|
152
|
Impact of Demographic Features, Lifestyle, and Comorbidities on the Clinical Expression of Hypertrophic Cardiomyopathy, file e2913fdb-c298-f688-e053-3705fe0a67e0
|
149
|
Left Ventricular Response to Cardiac Resynchronization Therapy: Insights From Hemodynamic Forces Computed by Speckle Tracking, file e2913fdc-9bab-f688-e053-3705fe0a67e0
|
148
|
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History, file e2913fdd-1dc4-f688-e053-3705fe0a67e0
|
147
|
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction, file e2913fdc-f9fb-f688-e053-3705fe0a67e0
|
144
|
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure, file e2913fdb-cb11-f688-e053-3705fe0a67e0
|
142
|
Chapter 9: Endomyocardial Biopsy, file e2913fdc-da6d-f688-e053-3705fe0a67e0
|
142
|
Historical Terminology, Classifications, and Present Definition of DCM., file e2913fdc-ddd2-f688-e053-3705fe0a67e0
|
140
|
Glomerular filtration rate: A prognostic marker in atrial fibrillation-A subanalysis of the AntiThrombotic Agents Atrial Fibrillation, file e2913fdc-aa9f-f688-e053-3705fe0a67e0
|
139
|
Critical role of lysosomes in the dysfunction of human Cardiac Stem Cells obtained from failing hearts, file e2913fdf-09ea-f688-e053-3705fe0a67e0
|
139
|
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy, file e2913fda-fba3-f688-e053-3705fe0a67e0
|
136
|
Chapter 13: Current Management and Treatment, file e2913fdd-055d-f688-e053-3705fe0a67e0
|
136
|
Simple scoring system to predict in-hospital mortality after surgery for infective endocarditis, file e2913fdb-ef1d-f688-e053-3705fe0a67e0
|
134
|
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone, file e2913fdd-28ae-f688-e053-3705fe0a67e0
|
134
|
Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata, file dd6c7b48-2891-46d0-bafb-8bf6302c9edf
|
132
|
MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy, file e2913fdb-ef20-f688-e053-3705fe0a67e0
|
130
|
Pulmonary Embolism Presenting with Pulmonary Infarction: Update and Practical Review of Literature Data, file e2e5f834-3edb-4930-ad2d-6e740b305ae2
|
130
|
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality, file bb12205f-8a96-45f7-a87a-c3d4aec6cfbc
|
129
|
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study, file 275f565e-7f11-45d2-b2fb-df1c10eb9581
|
127
|
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry, file 3e7eefc1-5132-42c2-9726-179ab7427e0a
|
127
|
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together, file e2913fdd-1899-f688-e053-3705fe0a67e0
|
126
|
Autophagy and Inflammasome Activation in Dilated Cardiomyopathy, file e2913fdd-2d7a-f688-e053-3705fe0a67e0
|
123
|
Chapter 11: Regenerative Medicine and Biomarkers for Dilated Cardiomyopathy, file e2913fdd-2494-f688-e053-3705fe0a67e0
|
120
|
Exome-chip meta-analysis identifies novel loci associated with cardiac conduction, including ADAMTS6, file e2913fdc-4aaa-f688-e053-3705fe0a67e0
|
119
|
Molecular and Cellular Mechanisms in Heart Failure, file e2913fdf-367d-f688-e053-3705fe0a67e0
|
118
|
Evidence of a double anaerobic threshold in healthy subjects, file d2df25dd-43cb-4fde-af30-a6a342d2a2ce
|
115
|
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy, file e2913fdd-786e-f688-e053-3705fe0a67e0
|
114
|
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives, file e2913fdd-055e-f688-e053-3705fe0a67e0
|
113
|
Detection of subjects with ischemic heart disease by using machine learning technique based on heart rate total variability parameters, file e2913fdd-f60b-f688-e053-3705fe0a67e0
|
113
|
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors, file e2913fdc-e2e5-f688-e053-3705fe0a67e0
|
111
|
Chapter 12: Prognostic Stratification and Importance of Follow-Up, file e2913fdc-eb75-f688-e053-3705fe0a67e0
|
111
|
Chapter 3: Pathophysiology, file e2913fdd-03b2-f688-e053-3705fe0a67e0
|
108
|
Chapter 14: Unresolved Issues and Future Perspectives, file e2913fdd-2496-f688-e053-3705fe0a67e0
|
108
|
PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity, file e2913fdc-434b-f688-e053-3705fe0a67e0
|
107
|
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy, file e2913fdf-8687-f688-e053-3705fe0a67e0
|
106
|
Sacubitril/Valsartan Induces Global Cardiac Reverse Remodeling in Long-Lasting Heart Failure with Reduced Ejection Fraction: Standard and Advanced Echocardiographic Evidences, file e2913fdd-55a0-f688-e053-3705fe0a67e0
|
105
|
Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling, file e2913fde-0f8b-f688-e053-3705fe0a67e0
|
104
|
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach, file e2913fdd-2495-f688-e053-3705fe0a67e0
|
103
|
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy, file e2913fdb-428c-f688-e053-3705fe0a67e0
|
96
|
Gene Therapy for the Heart Lessons Learned and Future Perspectives, file e2913fdf-3416-f688-e053-3705fe0a67e0
|
96
|
Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role, file 92ce5db7-d505-4631-8065-15f626ef5be1
|
95
|
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world, file e2913fdd-8efd-f688-e053-3705fe0a67e0
|
95
|
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy, file e2913fdd-52a2-f688-e053-3705fe0a67e0
|
92
|
Cardiac Magnetic Resonance in Primary Prevention of Sudden Cardiac Death, file e2913fdd-559e-f688-e053-3705fe0a67e0
|
92
|
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy, file a4a4b25b-8c22-4c1b-8154-e162ac59a90b
|
91
|
Standardizing the role of endomyocardial biopsy in current clinical practice worldwide, file 4b2c8317-9121-4273-8471-2c9e07d876fa
|
90
|
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy, file 468c9389-c517-4b5d-aeca-999914bd5b8c
|
88
|
Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients, file e2913fdf-a324-f688-e053-3705fe0a67e0
|
88
|
Impact of patient delay in a modern real world STEMI network, file e2913fdf-4c57-f688-e053-3705fe0a67e0
|
84
|
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy, file b94d515a-becd-4903-a261-cc573898540d
|
82
|
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study, file e2913fdf-31f2-f688-e053-3705fe0a67e0
|
82
|
Sudden cardiac death in cardiomyopathies: acting upon “acceptable” risk in the personalized medicine era, file ffbaeba5-94e0-467f-b575-01d8d5893864
|
81
|
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist?, file e2913fda-a49e-f688-e053-3705fe0a67e0
|
79
|
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy, file e2913fdd-c34a-f688-e053-3705fe0a67e0
|
78
|
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy, file e2913fde-bd7a-f688-e053-3705fe0a67e0
|
78
|
Totale |
30.789 |